Crossref
Multi-omics characterization of COVID-19 severity in a Korean cohort informs drug-repurposing candidates
Computational and Structural Biotechnology Journal · 03.11.2026
DOI: 10.34133/csbj.0283 ↗Kurz gefasst
Fachartikel in der Zeitschrift Computational and Structural Biotechnology Journal, online erschienen am 03.11.2026. Verfasst von Sangmi Ryou und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ryou, S., Jeong, C., Kim, T. Y., Go, M. J., Kim, J., & Jo, H. (2026). Multi-omics characterization of COVID-19 severity in a Korean cohort informs drug-repurposing candidates. Computational and Structural Biotechnology Journal. https://doi.org/10.34133/csbj.0283
Vancouver
Ryou S, Jeong C, Kim TY, Go MJ, Kim J, Jo H. Multi-omics characterization of COVID-19 severity in a Korean cohort informs drug-repurposing candidates. Computational and Structural Biotechnology Journal. 2026. doi:10.34133/csbj.0283
BibTeX
@article{Ryou2026,
author = {Ryou, Sangmi and Jeong, Chae-Hong and Kim, Tae Yong and Go, Min jin and Kim, Jungyeon and Jo, Hye-Yeong},
title = {Multi-omics characterization of COVID-19 severity in a Korean cohort informs drug-repurposing candidates},
journal = {Computational and Structural Biotechnology Journal},
year = {2026},
doi = {10.34133/csbj.0283}
}
EUVIMED